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& Abstract
Introduction: Between 2009 and 2011 a series of 26 articles
on evidence-basedmedicine for interventional pain medicine
according to clinical diagnoses were published. The high
number of publications since the last literature search
justified an update.
Methods: For the update an independent 3rd party, special-
ized in systematic reviews was asked in 2015 to perform the
literature search and summarize relevant evidence using
Cochrane and GRADE methodology to compile guidelines on
interventional pain management. The guideline committee
reviewed the information andmadea last updateonMarch1st
2018. The information from new studies published after the
research performed by the 3th party and additional observa-
tional studieswasused to incorporateother factors suchas side
effects and complications, invasiveness, costs and ethical
factors, which influence the ultimate recommendations.
Results: For the different indications a total of 113 inter-
ventions were evaluated. Twenty-seven (24%) interventions
were new compared to the previous guidelines and the
recommendation changed for only 3 (2.6%) of the interven-
tions.
Discussion: This article summarizes the evolution of the
quality of evidence and the strength of recommendations for
the interventional pain treatment options for 28 clinical pain
diagnoses. &
Key Words: interventional pain management, evidence-
basedmedicine, systematic review,GRADE, recommendations
INTRODUCTION
Clinical practice guidelines are statements that include
recommendations intended to optimize patient care that
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are established by a systematic review of evidence and an
assessment of the benefits and harms of alternative care
options.1 For guidelines to reflect the best available
evidence, it is important that they be based on a compre-
hensive systematic review of all available evidence. Guide-
lines, though much appreciated by clinicians, may rapidly
become outdated. Between 2009 and 2011, a series of
articles were published on recommendations for diagnosis
and treatment of 26 diagnoses. In particular, the evidence
on interventional pain management techniques was ana-
lyzed and used as the basis for the recommendations. The
recommendations were formulated according to a system
adapted from Guyatt2 by van Kleef et al.3 For a detailed
description of this scoring system, we refer the reader to
van Kleef et al.3 The guidelines were published in Pain
Practice.4–29 The large number of publications since the
previous literature search justifies an update.
Method of Reviewing the Literature
An independent company, Kleijnen Systematic Reviews
(KSR), was asked to review the literature.
This review aimed to identify and summarize relevant
evidence using Cochrane and Grading of Recommenda-
tions Assessment, Development and Evaluation
(GRADE) methodology to inform guidelines on inter-
ventional pain management.30,31 This objective was
achieved by conducting a review of existing systematic
reviews (SRs) and randomized controlled trials (RCTs)
for the conditions outlined in the research question.
RESEARCH QUESTION
What is the place for interventional pain management
techniques in the treatment algorithm of the following
conditions?
1. Trigeminal neuralgia
2. Cluster headache
3. Persistent idiopathic facial pain
4. Cervical radicular pain
5. Cervical facet pain
6. Cervicogenic headache
7. Whiplash-associated disorders
8. Occipital neuralgia
9. Thoracic radicular pain
10. Thoracic facet joint pain
11. Lumbosacral radicular pain
12. Failed back surgery syndrome
13. Pain due to spinal canal stenosis
14. Pain originating from the lumbar facet joints
15. Sacroiliac joint pain
16. Discogenic low back pain
17. Complex regional pain syndrome
18. Herpes zoster and postherpetic neuralgia
19. Painful diabetic polyneuropathy
20. Carpal tunnel syndrome
21. Meralgia paresthetica
22. Phantom pain
23. Traumatic plexus lesion
24. Chronic refractory angina pectoris
25. Ischemic pain in the extremities and Raynaud’s
phenomenon
26. Pain in chronic pancreatitis
27. Pain in patients with cancer
METHODS
Selection of the Literature
The search by the independent research company (KSR)
was performed in 2015. The search covered the period
2010 to 2015.
Inclusion Criteria
Studies that met the following criteria were eligible for
inclusion.
Participants. Patients (adults or children) had any of
the conditions under research.
Interventions. Interventional treatments were defined
as procedures targeting the source of the patient’s pain.
The interventions discussed in the previous guideline
were included, except for shoulder pain. Additionally, 2
new topics were added: failed back surgery syndrome
and spinal canal stenosis. A list of treatments catego-
rized by clinical diagnosis is presented in Appendix 1.
When we identified RCTs of interventional treatments
that were not listed in the protocol, the members of the
guideline committee decided on inclusion in the review.
Outcome. Inclusionwas not restricted based on outcome;
anyoutcomewas considered.Theprimaryoutcome,which
is alsomost often used in SRs andRCTs, is pain reduction;
improvement in function and quality of life were included
as well. There is little information regarding medication
use, but when available it was included.
Study design. SRs and RCTs were eligible for inclusion.
If no relevant RCTs were identified for any prespecified
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interventional technique of interest, then case-control or
cohort studies were included.
Literature Searches
Literature searches were conducted to identify relevant
studies for each of the conditions of interest. The
searches were carried out using a stepwise approach
according to study design:
 SRs
 RCTs
 Observational studies (case-controlorcohort studies)
SRs were identified by screening the in-house KSR
pain database of SRs. This database consists of SRs
identified by regular literature searches of a range of
bibliographic databases. Additionally, a search for
recent guidelines was undertaken.
The search strategies used to identify RCTs combined
relevant search terms comprising indexed keywords (eg,
medical subject headings [MeSH]) and text terms
appearing in the titles and/or abstracts of database
records for each of the target conditions. When search-
ing for RCTs where the quantity of literature is likely to
be large, the search strategies included an additional
facet of search terms for the interventional treatments of
interest for those particular conditions, for example,
cancer pain, thoracic pain, and angina pectoris.
Searchmethodsmet best practice standards in SRs.32,33
The search strategies were developed specifically for each
database and the keywords adapted according to the
configuration of each database. Where appropriate,
searches were limited to remove animal studies. Searches
were not limited by language or publication status.
1. SRs and guidelines
The following databases were searched for the KSR
pain database of SRs:
 Cochrane Database of Systematic Reviews (Wiley
Online Library)
 Database of Abstracts of Reviews of Effects
(Wiley Online Library)
 Medline In-Process Citations, Medline Daily
Update (OvidSP)
 Embase (OvidSP)
 Cumulative Index to Nursing and Allied Health
Literature (CINAHL; EBSCO)
 PsycINFO (OvidSP)
 Allied and Complementary Medicine Database
(AMED; ProQuest)
 National Guideline Clearinghouse (for recent
guidelines: www.guideline.gov/)
2. RCTs
The following databases were searched for RCTs
and, where appropriate, included a search filter designed
to identify RCTs:34
Medline (OvidSP)
Medline In-Process Citations, Medline Daily Update
(OvidSP)
PubMed (National Library of Medicine [NLM])
Embase (OvidSP)
Cochrane Central Register of Controlled Trials
(CENTRAL) (Wiley Online Library)
3. Observational studies
If no evidence from SRs and RCTS was identified,
the following databases were searched and included
a search filter designed to identify observational
studies:35
 Medline (OvidSP)
 Medline In-Process Citations, Medline Daily
Update (OvidSP)
 PubMed (NLM)
 Embase (OvidSP)
Reference Checking. The bibliographies of identified
research and review articles were checked for relevant
studies.
Handling of Citations. Identified references were
downloaded into Endnote reference management soft-
ware Thomson Reuter (Scientific) LLCC, London, UK
for further assessment and handling. Individual records
within the Endnote reference libraries were tagged with
search information, such as searcher, date searched,
database host, database searched, strategy name and
iteration, theme, or search question. To save time
removing duplicate records, as well as reviewer screen-
ing time, the results of searches for all chapters were
combined into one Endnote library.
Quality Assurance Within the Search Process. The
main Embase strategy for each search was indepen-
dently peer reviewed by a second information specialist
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using the Canadian Agency for Drugs and Technologies
in Health Peer Review checklist.13
Methods of Study Selection, Quality Assessment, and
Data Extraction
Study Selection. Two KSR reviewers independently
screened the titles and abstracts of all reports identified
by the searches; any discrepancies were discussed and
resolved by consensus. Full copies of all studies deemed
potentially relevant were obtained. One reviewer
assessed full text papers for inclusion, and a second
reviewer checked the decision; any disagreements were
resolved by consensus.
Data Extraction. Structured data extraction was per-
formed using a Microsoft Access (Microsoft Corpora-
tion, Redmond, WA, U.S.A.) database that was
developed specifically for the project. For interventional
studies, details on the following parameters were
extracted: participant characteristics, study design, brief
inclusion and exclusion criteria, brief intervention
details, details of outcomes assessed, and results. Data
for pain and available functionality and quality of life
were extracted by one KSR reviewer and checked by a
second; any disagreement was resolved by consensus.
Quality Assessment. SRs were assessed for method-
ological quality using the ROBIS tool.36 This tool aims
to assess the risk of bias in SRs and includes domains
covering study eligibility criteria, identification and
selection of studies, data collection and study appraisal,
synthesis and findings, and interpretation. Trials were
assessed for methodological quality using the Cochrane
Risk of Bias tool.31 This includes items covering
selection bias (random sequence generation and alloca-
tion concealment), performance bias (participant blind-
ing), detection bias (blinding of outcome assessors),
attrition bias (incomplete outcome data), and reporting
bias (selective reporting). There was also an additional
field for other sources of bias. For all tools, if at least 1 of
the domains was rated as “high,” the study was
considered at high risk of bias; if all domains were
judged as “low,” the trial was considered at low risk of
bias; otherwise the trial was considered to be at
“unclear” risk of bias.
Data Synthesis. If sufficient studies assessing similar
populations, interventions, comparators, and outcomes
were found, a formal meta-analysis was used to estimate
summary measures of effect. GRADE methods were
used to define the levels of evidence.
Integration of the Evidence Before 2010 and New
Publications Retrieved After 2015
The studies used in the previous 2010 guidelines were
usually included in SRs that were identified. When
studies were included in the previous guideline, but were
not included in the most recent SR, the panel retrieved
the publications used in the previous guideline. A
member of the guidelines committee who was an
epidemiologist judged the quality of studies that were
withheld from the previous guideline.
Last Update
Since the KSR search included studies published up to
2015, a new search of the abstracts was performed to
identify more recent publications (until March 1, 2018)
using the terms “diagnosis” and “intervention” for each
diagnosis and for the different interventional pain
management techniques.
When an SR was found, it was compared with the
review reported up to 2015. If no new information was
listed in the new SR, it was discarded. When new RCTs
or important observational studies were found, they
were discussed and included in the considerations
paragraph, and a judgment was made to what extent
this new information would influence (the strength of)
the recommendations.
The quality of the evidence found by KSR was
maintained.
The strength of recommendation could be adapted
based on the following factors:
 Studies published after 2015 providing relevant
information
 Risk–benefit balance
 Values and preferences such as:
 Clinical relevance
 Invasiveness
 Technical requirements needed to perform the
interventional pain management technique (de-
gree of specialization, need for special equipment)
 The need for shared decision making.
Table 1 shows the classification of the quality of
evidence, strength of recommendation, and description
of the recommendations.
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Validation
The chapters were placed on a closed website. Members
of the Dutch Society of Anesthesiologists; Flemish
Association of Anesthesiological Pain Management;
World Institute of Pain, Benelux section; and the
educational committee of the World Institute of Pain
were invited to give comments and feedback. All
remarks from the Netherlands and Belgium were
discussed in a plenary session. The comments from the
educational committee were reviewed by the guideline
committee. Where necessary, corrections were made.
RESULTS
The search strategy resulted in a large number of
references; for example, for the indications lumbar facet
joint pain, sacroiliac joint pain, and discogenic pain,
10,333 records after deduplication were screened for
inclusion in the study and 38 studies were finally
included in our review (22 for lumbar facet pain, 6 for
sacroiliac pain, and 10 for discogenic pain).
Table 2 summarizes the evolution of the evidence/
recommendation for the different diagnoses and the
relevant interventional pain management techniques.
The studies included in the quality assessment and those
used in the considerations, which may influence the
strength of recommendation, are described in the indi-
vidual chapters, which can be retrieved from https://
www.anesthesiologie.nl/publicaties/#filter=pijngeneesku
nde.
For the different indications, a total of 113 interven-
tions were evaluated. Twenty-seven interventions (24%)
were new compared to the 2010 guidelines, and the
recommendation changed for only 3 (2.6%) of the
interventions.
The scientific justification of the rating of the quality
of evidence and the strength of recommendations can be
retrieved from https://www.anesthesiologie.nl/publica
ties/#filter=pijngeneeskunde.
DISCUSSION
Quality of Evidence
The large number of publications retrieved for this
guideline project indicates the interest in the appropriate
use of interventional pain management techniques. The
quality of evidence may seem rather low and the
strength of the recommendations weak. However, this
must be viewed in the context of guideline methodology.
GRADE rates evidence based on RCTs as high quality,
but the confidence in evidence may be decreased for
several reasons, such as:
Study limitations
Inconsistency of results
Indirectness of evidence
Imprecision
Reporting bias
The quality of observational studies (eg, cohort and
case-control studies) starts with a “low quality” rating;
grading upwards may be warranted if the magnitude
of the treatment effect is very large, if there is evidence
of a dose-response relationship, or if all plausible
biases would decrease the magnitude of apparent
treatment.37
The fact that the quality of the evidence is rather low
does not mean that the effect of the treatment is
minimal; it indicates the need for clinical research.
However, performing RCTs for (interventional) pain
management techniques is hampered by several factors,
such as difficulty in blinding the patient and interven-
tionalist, patient refusal to enter a study with a risk of
receiving a noneffective treatment, and ethical concern
of withholding potential effective treatment from
patients who suffer from chronic intolerable pain. This
results in few selected RCTs, and when they are
available they are downgraded because of risks of bias
such as blinding and low number of participants.
The meaning of the GRADE rating is described in
Table 3.
Strength of recommendation, quality of evidence, and
size of the effect are not synonymous. When the quality
of the evidence is low, this does not mean that the
intervention is not effective. And the quality of the
evidence may be high, indicating that the intervention is
not effective.
The rating of the quality of evidence has a direct
impact on the strength of recommendation. The mem-
bers of the guideline committee considered factors such
as risk for complications, degree of invasiveness, and
Table 1. Classification of the Quality of Evidence,
Strength of Recommendation, and Description of the
Recommendation
Quality of Evidence
Strength of
Recommendation Recommendation
High Strong Must (not) be used
Moderate Moderate Should (not) be used
Low Weak Could (not) be used
Very low Very weak Could (not) be considered
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Table 2. Summary of the Recommendations*
Treatment
Recommendations
in 2010†
GRADE Level of
Evidence in 2015
Recommendations
in 2018
Trigeminal neuralgia
Microvascular decompression Very low Very weak
Stereotactic radiosurgery Very low Very weak
Radiofrequency treatment of the ganglion Gasseri 2 B+ Low Weak
Pulsed radiofrequency 2 B Very low Very weak
Cluster headache
Uni- or bilateral injection of nervus occipitalis Not graded Very weak
Radiofrequency treatment of ganglion pterygopalatinum 2 C+ Very low Weak
Stimulation of ganglion pterygopalatinum Very low Very weak
Occipital nerve stimulation 2 C+ Low Very weak
Persistent idiopathic facial pain
Pulsed radiofrequency of ganglion pterygopalatinum 2 C+ Very low Very weak
Radiofrequency of ganglion pterygopalatinum Very low Very weak
Cervical radicular pain
Interlaminar epidural corticosteroid administration 2 B+ Moderate Weak
Transforaminal epidural preservative-free dexamethasone 2 B (not
dexamethasone)
Very low Very weak
Pulsed radiofrequency treatment adjacent to de DRG 1 B+ Moderate Moderate
Radiofrequency treatment adjacent to de DRG 2 B+ Moderate Weak
Spinal cord stimulation 0 Not graded Very weak
Cervical facet joint pain
Intra-articular corticosteroid administration 0 Low Weak against
Therapeutic (repetitive) cervical medial branch injections of local anesthetic with or
without corticosteroid
2 B+ Moderate Weak
Radiofrequency treatment of ramus medialis of the ramus dorsalis 2 C+ Low Weak
Cervicogenic headache
Injection of the nervus occipitalis major with local anesthetic with or without steroid 1 B+ Moderate Weak
Injection of atlanto-axial joint with local anesthetic with or without steroid 2 C Not graded Weak against
Radiofrequency treatment of cervical ramus medialis 2 B+/ Very low Very weak
Pulsed radiofrequency treatment of nervus occipitalis major Low Weak
Pulsed radiofrequency treatment of atlanto-axial joint Not graded Very weak
Pulsed radiofrequency of cervical DRG (C2–C3) 0
Whiplash-associated disorder
Botulinum toxin injections 2 B Moderate Moderate against
Radiofrequency treatment of cervical ramus medialis of the ramus dorsalis 2 B+ Low Moderate
Intra-articular corticosteroid injections 2 C Very low Very weak against
Occipital neuralgia
A single infiltration of the nervi occipitales with local anesthetic and corticosteroids 2 C+ Very low Very weak
Pulsed radiofrequency of the nervi occipitales 2 C+ Very low Weak
Pulsed radiofrequency adjacent to the DRG 0
Peripheral nerve stimulation 2 C+ Very low Very weak
Botulinum toxin injections 2 C+/ Very low Very weak
Stimulation of the nervi occipitales 2 C+ Very low Very weak
Thoracic radicular pain syndrome
Intercostal nerve blocks 0 Not graded Not applicable
(Pulsed) radiofrequency of thoracic DRG 2 C+ Low Weak
Pain originating from the thoracic facet joint
Addition of corticosteroids to local anesthetic for thoracic medial branch blocks High Moderate against
Lumbosacral radicular pain
Epidural corticosteroid administration (interlaminar, transforaminal contained
herniation, and transforaminal extruded herniation)
Moderate Weak
Epidural TNF-a inhibitors Low Weak against
Radiofrequency treatment adjacent to lumbar DRG 2 A Moderate Moderate against
Pulsed radiofrequency treatment adjacent to lumbar DRG 2 C+ Moderate Moderate
Failed back surgery syndrome
Adhesiolysis 2 B+/ Very low Very weak
Epiduroscopy 2 B +/ Moderate Weak
Spinal cord stimulation (tonic) 2 A+ Moderate Moderate
Spinal cord stimulation (HF-10) Not graded Moderate
Subcutaneous stimulation as add-on to spinal cord stimulation Not graded Very weak
Pain originating from the lumbar facet joints
Intra-articular injection of local anesthetic with or without corticosteroid 2 B+/ Low Very weak
Radiofrequency treatment of the ramus medialis of the ramus dorsalis 1 B+ Low Weak
Pulsed radiofrequency treatment of ramus medialis of the ramus dorsalis Low Very weak against
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Table 2. (Continued)
Treatment
Recommendations
in 2010†
GRADE Level of
Evidence in 2015
Recommendations
in 2018
Spinal canal stenosis
Spinal cord stimulation Very low Very weak
Pulsed radiofrequency treatment adjacent to DRG Moderate Moderate
Epidural local injections (without steroids) Low Weak
Epidural corticosteroid injections High Moderate against
Sacroiliac joint pain
Intra-articular corticosteroid injections 1 B+ Low Weak
Radiofrequency treatment of rami dorsalis and lateralis (palisade) 2 C+ Very low Very weak
Radiofrequency treatment of rami dorsalis and lateralis (palisade) SIJ pain due to
ankylosing spondylitis
Moderate Moderate
Radiofrequency treatment of rami dorsalis and lateralis (simplicity) Not graded Moderate against
Pulsed radiofrequency treatment of rami dorsalis and lateralis 2 C+ Not graded Very weak
Radiofrequency treatment of ramus dorsalis at L4–L5 and cooled radiofrequency of the
ramus lateralis
2 B+ Low Weak
Cooled radiofrequency treatment of ramus dorsalis at L4–L5 and ramus lateralis Moderate Moderate
Discogenic pain
Intradiscal methylene blue injection Moderate Weak
Intradiscal corticosteroid injection 2 B Low Weak against
Intradiscal radiofrequency treatment 2 B+/ Low Weak against
Intradiscal electrothermal therapy Low Weak
Intradiscal pulsed radiofrequency treatment 2 B+/ Very low Very weak
Intradiscal biacuplasty 0 Moderate Moderate
Disctrode 0
Radiofrequency treatment of ramus communicans 2 B + Very low Very weak against
Complex regional pain syndrome
Sympathetic blocks with local anesthetics 2 B+ Moderate Moderate against
Thoracic block (T2–T3) with ropivacaine and triamcinolone Low Weak
IV regional blocks with guanethidine 2 A Moderate Moderate against
Spinal cord stimulation 2 B+ Moderate Moderate
DRG stimulation (for lower extremity CRPS) Moderate Moderate
Peripheral nerve stimulation 2 C+ Very low Very weak
Low-dose IV ketamine Moderate Weak
Herpes zoster and postherpetic neuralgia
Acute phase: epidural injection of corticosteroid with local anesthetics 2 B+ Moderate Moderate
Acute phase: paravertebral injections of corticosteroids with local anesthetics Moderate Moderate
Acute phase: repeated epidural injections of corticosteroid with local anesthetics and
epinephrine
Moderate Weak
Acute phase: stellate ganglion block 2 C+ Low Weak
Treatment of postherpetic neuralgia: epidural corticosteroid injections or combined
therapy with intrathecal midazolam
0 Low Weak
Treatment of postherpetic neuralgia: sympathetic nerve block 2 C+ Very low Very weak against
Treatment of postherpetic neuralgia: spinal cord stimulation 2 C+ Very low Very weak
Treatment of postherpetic neuralgia: pulsed radiofrequency on intercostal nerve Moderate Moderate
Treatment of postherpetic neuralgia: pulsed radiofrequency adjacent to DRG Very weak Moderate
Treatment of postherpetic neuralgia: intrathecal administration of corticosteroid Low Strong against
Treatment of postherpetic neuralgia: lumbar sympathetic block Very low Very weak
Painful diabetic polyneuropathy
Spinal cord stimulation 2 C+ Moderate Moderate
Lumbar sympathetic block Very low Very weak
Meralgia paresthetica
Infiltration of LFCB with local anesthetic with or without corticosteroid 2 C+ Very low Very weak
Pulsed radiofrequency of LFCB 0 Very low Very weak
Spinal cord stimulation 0 Not graded Very weak
Carpal tunnel syndrome
Intracarpal corticosteroid injection(s) 1 B+ Moderate Moderate
Pulsed radiofrequency treatment of median nerve 0 Very low Very weak
Phantom pain
Pulsed radiofrequency treatment of the most tender part of the neuroma 0 Very low Very weak
Spinal cord stimulation 0 Very low Very weak
DRG stimulation Very low Very weak
Traumatic plexus lesion
Spinal cord and DRG stimulation 0 Not graded Very weak
Chronic refractory angina pectoris
Spinal cord stimulation 2 B+ Low Weak
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technical requirements to formulate a strength of
recommendation. A treatment option with low-quality
evidence and a weak recommendation may be preferred
over a treatment with high-quality evidence when the
former has fewer risks for complications and/or is less
invasive.
For example, in the judgment of epidural corticos-
teroid injections for the treatment of spinal canal
stenosis, high-quality evidence based on several SRs of
13 studies showed no significant difference in pain
reduction between the groups treated with corticos-
teroids compared to the group treated with local
anesthetics. This observation, together with considera-
tions on the potential side effects and complications of
corticosteroids, led to the recommendation against the
use of corticosteroids. The epidural administration of
local anesthetics alone is recommended.
Another example is in the treatment of postherpetic
neuralgia. Pulsed radiofrequency treatment of the dorsal
root ganglion has a very weak quality of evidence, but
this treatment is documented to be rather easy to
perform and safe; therefore, the strength of the recom-
mendation is upgraded to moderate.
Further Research
When the recommendation is very low, there is a high
need for more research.
Each intervention that received a very weak recom-
mendation should be performed in the context of a
study, which means at least the systematic recording of
 Patient characteristics
 Diagnostic process
 Treatment, including the details of the technique
concerned
 Evaluation of the result (preferably VAS, Euro-
Qol, and a complaint-specific scale over 3, 6, and
12 months)
 Recording of side effects and complications
 Systematic reporting of the results.
Table 2. (Continued)
Treatment
Recommendations
in 2010†
GRADE Level of
Evidence in 2015
Recommendations
in 2018
Raynaud’s phenomenon
Radiofrequency of T2–T3 and T2 thermolesion with a local application of phenol 2 C+ Very low Very weak
Spinal cord stimulation Very low Very weak
Ischemic pain of the extremities
Sympathectomy 2 B+/ Not graded Very weak
Spinal cord stimulation 2 B+/ High Moderate
Chronic pancreatitis
Plexus coeliacus block with local anesthetic and corticosteroid Low Weak against
Splanchnic nerve block 2 C+
(radiofrequency)
Very low Very weak
Spinal cord stimulation 2 C+ Very low Very weak
Pain in patients with cancer
Intrathecal drug administration 2 B+ Moderate Weak
Epidural drug administration 2 C+ Very low Very weak
Spinal cord stimulation Very low Very weak
Cervical percutaneous cordotomy 2 C+ Very low Very weak
Neurolytic plexus coeliacus block 2 A+ High Strong
Neurolytic plexus hypogastricus block 2 C+ Low Weak
Intrathecal phenolization of lower sacral roots of cauda equina (lower end block) 0 Very low Very weak
Kyphoplasty 2 B+ Not graded Very weak
Vertebroplasty 2 B+ Very low Very weak
*2010 recommendations as reported in the previous guideline; the level of evidence in 2015 as identified by independent evaluation using GRADE; and the strength of
recommendation as updated by the Guideline Committee in 2018, taking into consideration newer publications and potential risks for side effects and complications.
†A is the highest level of evidence (various RCTs of good quality), B stands for RCTs with methodological limitations or large observational studies and C stands for observational
studies or case series.3
CRPS, chronic regional pain syndrome; DRG, dorsal root ganglion; GRADE, Grading of Recommendations Assessment, Development and Evaluation; HF-10, High frequency 10-kHz
stimulation; LFCB, lateral femoral cutaneous nerve; SIJ, sacroiliac joint; TNF-a, tumor necrosis factor-a.
Table 3. Interpretation of the Quality of Evidence
High Much confidence that real effect is close to observed effect
Moderate Moderate confidence that real effect is close to observed
effect, but there is a possibility that it is
substantially different
Low Restricted confidence that real effect is close to observed
effect, the real effect can be substantially different than
the observed effect
Very low Little confidence that real effect is close to observed effect;
the real effect is probably substantially different from the
observed effect
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The aim is thus to accumulate information that
enables estimation of the value of the technique when it
has been applied to a larger number of patients. If these
results are positive, they may then lead to the justifica-
tion for a prospective randomized study.3
Critical Look at Guidelines
Guidelines have gained in popularity because clinicians
have easy access to the recommendations that may
facilitate their daily work. These guidelines may have an
immense impact, because they act as a standard of care
and may be used to devise national and local protocols,
measure physician performance, and evaluate adherence
to standards. They can also be used as expert testimony
in cases of litigation and malpractice.38 There are,
however, some points that deserve attention.
The recommendations formulated in guidelines are
valid for a specific patient population; however, they
may not be valid for the individual patient with
comorbidities. This stresses the role of the clinician to
select a treatment based on the complete medical picture
of the patient.
Furthermore, there is an increasing number of guide-
lines that are not performed according to the rigorous
methodology advocated by scientific groups such as the
Cochrane collaboration. A recent article in the Euro-
pean Journal of Anaesthesiology described the different
factors that may influence the interpretation of the
literature.38 The authors listed a methodological short-
age in many published SRs, the apparent ignorance
among reviewers and editors of scientific journals to
methodological issues and shortcomings of SRs, the
influence of sponsors on research outcome, financial
links of principal investigators of clinical trials that are
strongly associated with a positive clinical trial outcome,
conflicts of interest and lack of methodological knowl-
edge of peer reviewers, scientific fraud promoted by the
financial incentives of scientific publications, and the
poor quality of published clinical trials.38
Towards an Integrated Treatment Plan
Pain is a complex physical, psychosocial, ethnocultural,
affective-cognitive, and environmental phenomenon.
No single treatment can influence all these aspects and,
therefore, a multidisciplinary and multimodal approach
has been advocated. For the management of chronic
pain discussed in this guideline, a stepwise approach is
indicated. Firstly, conservative treatment options should
be used to their full extent. Secondly, interventional
treatment can be used. In the design of a treatment
algorithm, the first parameter to consider is the efficacy
of the treatment, but secondarily the grade of invasive-
ness of the intervention should be taken into consider-
ation. As stated earlier, quality of evidence is not
synonymous with effectiveness and use of healthcare
resources.
The correct application of interventional pain man-
agement techniques requires an excellent knowledge of
the neuroanatomy, experience in the interpretation of
the images obtained during the procedure, and adequate
training. It is obvious that a more complicated inter-
vention can only be performed by a well-trained and
experienced physician. Therefore, it is preferred that
such interventions be performed in specialized centers.39
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APPENDIX 1
Eligible Populations and Interventions
Population Interventional treatments
Trigeminal neuralgia Surgical microvascular decompression
Stereotactic radiation therapy, gamma knife
Percutaneous balloon microcompression
Radiofrequency treatment of the Gasserian ganglion
Pulsed RF treatment of the Gasserian ganglion
Cluster headache RF treatment of the pterygopalatine ganglion (sphenopalatinum)
Occipital nerve stimulation
Persistent idiopathic facial pain Pulsed RF treatment of the ganglion pterygopalatinum (sphenopalatinum)
Cervical radicular pain Interlaminar epidural corticosteroid administration
Transforaminal epidural corticosteroid administration
RF treatment adjacent to the cervical ganglion spinale (DRG)
Pulsed RF treatment adjacent to the cervical ganglion spinale (DRG)
Spinal cord stimulation
Cervical facet pain Intra-articular injections
Therapeutic (repetitive) cervical ramus medialis (medial branch) of the ramus dorsalis block (local anesthetic with or
without corticosteroid)
RF treatment of the cervical ramus medialis (medial branch) of the ramus dorsalis
Cervicogenic headache Injection of nervus occipitalis major with corticosteroid + local anesthetic Injection of atlanto-axial joint with
corticosteroid + local anesthetic
RF treatment of the cervical ramus medialis (medial branch) of the ramus dorsalis Pulsed RF treatment of the cervical
ganglion spinale (DRG) (C2 to C3)
Whiplash-associated disorders Botulinum toxin type A
Intra-articular corticosteroid injection
RF treatment of the cervical ramus medialis (medial branch) of the ramus dorsalis
Occipital neuralgia Single infiltration of the nervi occipitales with local anesthetic and corticosteroids
Pulsed RF treatment of the nervi occipitales Pulsed
RF treatment of the cervical ganglion spinale (DRG)
Subcutaneous stimulation of the nervi occipitales
Botulinum toxin A injection
Thoracic pain Intercostal block
RF treatment of thoracic ganglion spinale (DRG)
Pulsed RF treatment of thoracic ganglion spinale (DRG)
Lumbosacral radicular pain Interlaminar epidural corticosteroid administration
Transforaminal epidural corticosteroid administration in “contained herniation” Transforaminal epidural
corticosteroid administration in “extruded herniation”
RF lesioning adjacent to the lumbar ganglion spinale (DRG)
Pulsed RF treatment adjacent to the lumbar ganglion spinale (DRG)
Spinal cord stimulation (FBSS only)
Adhesiolysis–epiduroscopy
Pain originating from the lumbar
facet joints
Intra-articular corticosteroid injections
RF treatment of the lumbar rami mediales (medial branches) of the dorsal ramus
Sacroiliac joint pain Therapeutic intra-articular injections with corticosteroids and local anesthetic
RF treatment of rami dorsales and rami laterals
Pulsed RF treatment of rami dorsales and rami laterals
Cooled/RF treatment of the rami laterales
Coccygodynia Local injections corticosteroids/local anesthetic
Intradiscal corticosteroid injections, ganglion impar block, RF ganglion impar, caudal block Neurostimulation
Discogenic low back pain Intradiscal corticosteroid administration
RF treatment of the discus intervertebralis
Intradiscal electrothermal therapy
Biacuplasty
Disctrode
RF of the ramus communicans
Complex regional pain syndrome Intravenous regional block guanethidine
Ganglion stellatum (stellate ganglion) block
Lumbar sympathetic block
Plexus brachialis block
Epidural infusion analgesia Spinal cord stimulation
Peripheral nerve stimulation
Herpes zoster and post-herpetic
neuralgia
Interventional pain treatment of acute herpes zoster
Epidural corticosteroid injections
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Appendix A. (Continued)
Population Interventional treatments
Sympathetic nerve block
One-time epidural corticosteroid injection
Repeated paravertebral injections
Sympathetic nerve block
Epidural corticosteroid injections
Sympathetic nerve block
Intrathecal injection
Spinal cord stimulation
Painful diabetic polyneuropathy Spinal cord stimulation
Carpal tunnel syndrome Local injections with corticosteroids
Pulsed RF treatment median nerve
Meralgia parasthetica Lateral femoral cutaneous nerve (LFCN) infiltration with local anesthetic  corticosteroid
Pulsed RF treatment of LFCN
Spinal cord stimulation
Phantom pain Pulsed RF treatment of the stump neuroma Pulsed RF treatment adjacent to the spinal ganglion (DRG)
Spinal cord stimulation
Traumatic plexus lesion Spinal cord stimulation
Pain in patients with cancer Intrathecal medication delivery
Epidural medication delivery
Cervical cordotomy
Neurolytic plexus coeliacus block
Neurolytic nervus splanchnicus block
Neurolytic plexus hypogastricus block
Intrathecal phenolization of lower sacral roots of cauda equine
Vertebroplasty
Kyphoplasty
Chronic refractory angina
pectoris
Spinal cord stimulation
Ischemic pain of the extremities
and Raynaud’s phenomenon
Sympathectomy
Spinal cord stimulation
Pain in chronic pancreatitis RF nervus splanchnicus block
Spinal cord stimulation
DRG, dorsal root ganglion; FBSS, failed back surgery syndrome; RF, radiofrequency.
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